Selective inhibition of the tyrosine kinase pp60src by analogs of 5,10-dihydropyrimido[4,5-b]quinolin-4(1H)-one
- 1 May 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (9) , 1007-1010
- https://doi.org/10.1016/0960-894x(95)00157-o
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Identification of Tricyclic Analogs Related to Ellagic Acid as Potent/Selective Tyrosine Protein Kinase InhibitorsJournal of Medicinal Chemistry, 1994
- pp60c‐src protein kinase activity in human gastric carcinomasInternational Journal of Cancer, 1990
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVOThe Lancet, 1986
- Amidinoacetamides in the synthesis of pyrimidines, imidazoles, and purinesJournal of the Chemical Society, Perkin Transactions 1, 1976
- Heterocyclic studies. Part XXXVIII. Synthesis and disproportionation of pyrimido[4,5-b]quinolinium saltsJournal of the Chemical Society, Perkin Transactions 1, 1976
- An unusual arylation of 4‐oxo‐3,4‐dihydropyrimido[4,5‐b]quinolineJournal of Heterocyclic Chemistry, 1971